A bill to require the United States Postal Service to sell the Alzheimer's semipostal stamp for 6 additional years.
- Sponsor
- Sen. Markey, Edward J. [D-MA]
- Committees
- Homeland Security and Governmental Affairs Committee (primary)
- Last action
- Jul 23, 2026
Bottom line
This bill extends a popular semipostal stamp program for six years, providing a continued voluntary funding stream for Alzheimer's disease research through public contributions.
What it actually does
This bill mandates the United States Postal Service (USPS) to continue selling the Alzheimer's semipostal stamp for an additional six years beyond its scheduled discontinuation date. The proceeds generated from the sale of these stamps, after covering USPS costs, are to be transferred to the National Institutes of Health (NIH) to fund medical research related to Alzheimer's disease. The bill also includes a technical provision ensuring this stamp's sale does not conflict with existing limitations on the number of semipostal stamps offered concurrently.
Proponents argue
Supporters argue that extending the Alzheimer's semipostal stamp offers a simple, effective, and voluntary mechanism for the public to contribute directly to critical Alzheimer's disease research without imposing new taxes or mandatory government spending. They emphasize the ongoing and urgent need for research funding to combat a devastating disease and highlight the proven success and public acceptance of the existing stamp program as a valuable fundraising tool.
Opponents contend
Critics might argue that while the cause is undeniably worthy, relying on the Postal Service for fundraising, even for popular causes, could be seen as a diversion from its core mission of mail delivery. Some may also contend that such funding should primarily come from direct federal appropriations, ensuring a more stable and predictable revenue stream for research, rather than depending on voluntary, potentially fluctuating, stamp sales.
The bill is exceptionally short and clearly written, making it highly accessible for any interested reader to understand its provisions quickly.
Section 1(b)
Mandatory Extension of Alzheimer's Semipostal Stamp Sale
This provision legally requires the United States Postal Service (USPS) to continue selling the Alzheimer's semipostal stamp for an additional six-year period. This extension commences on the date the USPS would have otherwise ceased selling the stamp. The explicit purpose is to provide a convenient and ongoing method for members of the public to contribute funds specifically earmarked for medical research into Alzheimer's disease.
Supporters argue
Supporters argue that extending the sale of the Alzheimer's semipostal stamp is a highly effective and popular way to generate voluntary contributions for vital medical research. They highlight that the program has already proven successful in raising funds and that continuing it allows the public to easily support a cause with widespread impact, without requiring new taxes or direct government appropriations.
Critics contend
No specific organized opposition is typically raised against extending semipostal stamps for popular causes like Alzheimer's research. However, some might generally argue that the Postal Service's primary mission is mail delivery, and mandating its involvement in fundraising, even for worthy causes, could be seen as a distraction or an expansion of its role beyond its core functions.
Tradeoffs
The primary tension involves balancing the public's desire to contribute to a worthy cause with the administrative burden on the Postal Service and the potential for similar requests for other causes. It also navigates the balance between relying on voluntary public contributions and direct government funding for critical medical research.
This subsection clarifies that during the extended sales period, the Alzheimer's semipostal stamp will be considered issued under the authority of this specific Act (S. 5119), rather than under the general discretionary authority of section 416(b) of title 39, United States Code. Crucially, this includes bypassing any limitations under section 416 (or its regulations) regarding whether more than one semipostal stamp may be offered for sale at the same time.
Section 1(c)(3)
Why it matters:This is a standard legislative technique to ensure the new mandate overrides or clarifies existing law without requiring a full amendment of the underlying statute. It's a necessary technical detail to ensure the bill's effective implementation and prevent unintended conflicts with other semipostal stamp programs.
Case for: Supporters argue this is a necessary technical clarification to ensure the continued sale of the Alzheimer's stamp does not inadvertently conflict with or prevent the sale of other semipostal stamps that the USPS might offer under its general discretionary authority. It provides legal certainty for the program's continuation and allows for multiple charitable stamps to coexist.
Case against: Critics might argue that such provisions, while technical, can be used to circumvent broader legislative intent or limitations on government programs. If the original intent of 39 U.S.C. 416 was to limit the number of semipostal stamps, this provision explicitly overrides that limitation for this specific stamp, potentially opening the door to a proliferation of such stamps without broader review.
Estimated impact: Ensures the Alzheimer's semipostal stamp can coexist with other semipostal stamps, potentially maximizing overall charitable revenue from stamp sales without legal conflict or requiring the USPS to choose between worthy causes.